Select country set
Menu Shopping cart 0,00 Search
Manufactured by BioVendor

Resistin Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:Cysteine-rich secreted protein FIZZ3, Adipose tissue-specific secretory factor, ADSF, C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein, Cysteine-rich secreted protein A12-alpha-like 2, RETN, FIZZ3, HXCP1, RSTN, UNQ407/PRO1199
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

RD191016100 96 wells (1 kit)
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate

Sample Requirements

35 µl/well


At ambient temperature. Upon receipt, store the product at the temperature recommended below.


Store the kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1–50 ng/ml

Limit of Detection

0.012 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 5.9%

Inter-assay (Run-to-Run)

n = 5; CV = 7.6%

Spiking Recovery


Dilution Linearity



  • bovine Non-detectable
  • cat Non-detectable
  • dog Non-detectable
  • goat Non-detectable
  • hamster Non-detectable
  • horse Yes (recommended dilution 1:6)
  • rabbit Non-detectable
  • rat Non-detectable
  • sheep Non-detectable
  • chicken Not tested
  • human Yes
  • monkey Yes (recommended dilution 1:3)
  • mouse Yes (recommended dilution 1:3)
  • pig Yes (recommended dilution 1:3)


More about Resistin on BioVendor Scientific Blog



  • European Union: for in vitro diagnostic use
  • Rest of the world: for research use only!
  • The total assay time is less than 4 hours
  • The kit measures total resistin in serum and plasma (EDTA, citrate, heparin)
  • Assay format is 96 wells
  • Quality Controls are human serum based
  • Standard is recombinant protein based
  • Components of the kit are provided ready to use, concentrated or lyophilized

Research topic

Diabetology - Other Relevant Products, Energy metabolism and body weight regulation


Resistin, a product of the RSTN gene, is a peptide hormone belonging to the class of cysteinerich
secreted proteins which is termed the RELM family, and is also described as ADSF
(Adipose Tissue-Specific Secretory Factor) or FIZZ3 (Found in Inflammatory Zone). Human
resistin contains 108 amino acids as a prepeptide, and its hydrophobic signal peptide is
cleaved before its secretion. Resistin circulates in human blood as a dimeric protein consisting
of two 92 amino acid polypeptides, which are disulfide-linked via Cys26.

Much of the early investigations about the resistin molecule are based on the mouse model.
Resistin, produced and secreted primarily by adipocytes in mice, acts on skeletal muscle
myocytes, hepatocytes and adipocytes themselves so that it reduces their sensitivity to insulin.
Steppan et al. have suggested that resistin suppresses the ability of insulin to stimulate
glucose uptake. Other studies have shown that mouse resistin increases during the
differentiation of adipocytes, but it also seems to inhibit adipogenesis.

Compared to the mouse model, human adipogenic differentiation is likely to be associated with
a down regulation of resistin gene expression. On the other hand, resistin was found to be
expressed at high levels in human monocytes, macrophages and bone marrow.
Recent investigations have shown that human resistin is correlated with metabolic syndrome
and obesity-related disorders. Malo et al. have reported that resistin levels are positively
associated with waist circumference, tumor necrosis factor-a, and insulin resistance assessed
by the homeostasis model, and inversely correlated with total cholesterol, HDL cholesterol, and
LDL cholesterol. Moreover, Sadhasiv et al. found a positive correlation of SAT (subcutaneous
adipose tissue) resistin mRNA expression with serum resistin, BMI and insulin resistance
(HOMA index).

Based on the above reports human resistin might be an important marker that acts as the link
between obesity and insulin resistance. Resistin can play a role also in inflammation processes
and in atherosclerosis.
Clinical use and areas of investigation: Energy metabolism and body weight regulation, Metabolic syndrome, Inflammation, Atherosclerosis

Product References (198)


  • Aknc A, Karakurt C, Gurbuz S, Elkran O, Nalbantoglu O, Kocak G, Guldur T,Yologlu S. Association of cardiac changes with serum adiponectin and resistinlevels in obese and overweight children. J Cardiovasc Med (Hagerstown). 2013Mar;14(3):228-34. doi: 10.2459/JCM.0b013e328351674e. PubMed PMID: 22441215. See more on PubMed
  • Aller R, de Luis DA, Fernandez L, Calle F, Velayos B, Olcoz JL, Izaola O,Sagrado MG, Conde R, Gonzalez JM. Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. Dig Dis Sci. 2008 Apr;53(4):1088-92. Epub 2007 Oct 13. PubMed PMID: 17934820. See more on PubMed
  • Aller R, De Luis DA, Izaola O, González Sagrado M, Conde R, Alvarez T, PachecoD, Velasco MC. Role of -55CT polymorphism of UCP3 gene on non alcoholic fattyliver disease and insulin resistance in patients with obesity. Nutr Hosp. 2010Jul-Aug;25(4):572-6. PubMed PMID: 20694293. See more on PubMed
  • Al-Mrayat M, Samarasinghe Y, Treml H, Munro N, Shotliff K, McIntosh C, FeherMD. A new cause of neuroglycopenia: "missing the point". Diabet Med. 2004May;21(5):497. PubMed PMID: 15089798. See more on PubMed
  • Anderlová K, Dolezalová R, Housová J, Bosanská L, Haluzíková D, Kremen J,Skrha J, Haluzík M. Influence of PPAR-alpha agonist fenofibrate on insulinsensitivity and selected adipose tissue-derived hormones in obese women with type2 diabetes. Physiol Res. 2007;56(5):579-86. Epub 2006 Dec 19. PubMed PMID:17184146. See more on PubMed
  • Annaloro C, Usardi P, Airaghi L, Giunta V, Forti S, Orsatti A, Baldini M,Delle Volpe A, Lambertenghi Deliliers G. Prevalence of metabolic syndrome inlong-term survivors of hematopoietic stem cell transplantation. Bone MarrowTransplant. 2008 May;41(9):797-804. doi: 10.1038/sj.bmt.1705972. Epub 2008 Jan14. PubMed PMID: 18195686. See more on PubMed
  • Antonio de Luis D, Aller R, Izaola O, Primo D, Bachiller R. The rs10401670variant in resistin gene improved insulin resistance response and metabolicparameters secondaries to weight loss after a hypocaloric diet. Clin Nutr ESPEN. 2016 Aug;14:14-18. doi: 10.1016/j.clnesp.2016.04.028. Epub 2016 May 14. PubMedPMID: 28531393. See more on PubMed
  • Asgeirsson T, Zhang S, Khoo SK, Resau JH, Dujovny N, Senagore AJ. Serumadiponectin, resistin, and circulating soluble receptor for advanced glycationend products in colectomy patients. Mediators Inflamm. 2011;2011:916807. doi:10.1155/2011/916807. Epub 2011 Sep 7. PubMed PMID: 21912448; PubMed CentralPMCID: PMC3168899. See more on PubMed
  • Auguet T, Aragonès G, Guiu-Jurado E, Berlanga A, Curriu M, Martinez S,Alibalic A, Aguilar C, Camara ML, Hernández E, Ruyra X, Martín-Paredero V,Richart C. Adipo/cytokines in atherosclerotic secretomes: increased visfatinlevels in unstable carotid plaque. BMC Cardiovasc Disord. 2016 Jul 8;16(1):149.doi: 10.1186/s12872-016-0320-5. PubMed PMID: 27391230; PubMed Central PMCID:PMC4939016. See more on PubMed
  • Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, Broch M,Aguilar C, Olona M, Porras JA, Hernandez M, Sabench F, del Castillo D, Richart C.New adipokines vaspin and omentin. Circulating levels and gene expression inadipose tissue from morbidly obese women. BMC Med Genet. 2011 Apr 28;12:60. doi: 10.1186/1471-2350-12-60. PubMed PMID: 21526992; PubMed Central PMCID: PMC3107780. See more on PubMed
  • Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T.Correlation between serum resistin level and adiposity in obese individuals. ObesRes. 2003 Aug;11(8):997-1001. PubMed PMID: 12917505. See more on PubMed
  • Azuma K, Oguchi S, Matsubara Y, Mamizuka T, Murata M, Kikuchi H, Watanabe K,Katsukawa F, Yamazaki H, Shimada A, Saruta T. Novel resistin promoterpolymorphisms: association with serum resistin level in Japanese obeseindividuals. Horm Metab Res. 2004 Aug;36(8):564-70. PubMed PMID: 15326567. See more on PubMed
  • Bahijri SM, Ajabnoor G, Hegazy GA, Alsheikh L, Moumena MZ, Bashanfar BM,Alzahrani AH. Supplementation with Oligonol, Prevents Weight Gain and ImprovesLipid Profile in Overweight and Obese Saudi Females. Curr Nutr Food Sci. 2018Apr;14(2):164-170. doi: 10.2174/1573401313666170609101408. PubMed PMID: 29853817;PubMed Central PMCID: PMC5907059. See more on PubMed
  • Bahr MJ, Ockenga J, Böker KH, Manns MP, Tietge UJ. Elevated resistin levels incirrhosis are associated with the proinflammatory state and altered hepaticglucose metabolism but not with insulin resistance. Am J Physiol EndocrinolMetab. 2006 Aug;291(2):E199-206. Epub 2006 Feb 14. PubMed PMID: 16478779. See more on PubMed
  • Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Plasmaresistin concentration, hepatic fat content, and hepatic and peripheral insulinresistance in pioglitazone-treated type II diabetic patients. Int J Obes RelatMetab Disord. 2004 Jun;28(6):783-9. PubMed PMID: 15024400. See more on PubMed
  • Barac A, Campia U, Matuskey LA, Lu L, Panza JA. Effects of peroxisomeproliferator-activated receptor-gamma activation with pioglitazone on plasmaadipokines in nondiabetic patients with either hypercholesterolemia orhypertension. Am J Cardiol. 2008 Apr 1;101(7):980-5. doi:10.1016/j.amjcard.2007.11.058. PubMed PMID: 18359318. See more on PubMed
  • Becer E, Çırakoğlu A. Effect of the Pro12Ala Polymorphism of the PeroxisomeProliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels inObese Subjects. Balkan J Med Genet. 2017 Jun 30;20(1):71-80. doi:10.1515/bjmg-2017-0007. eCollection 2017 Jun 30. PubMed PMID: 28924543; PubMedCentral PMCID: PMC5596824. See more on PubMed
  • Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, Arteel GE.Metformin prevents endotoxin-induced liver injury after partial hepatectomy. JPharmacol Exp Ther. 2006 Mar;316(3):1053-61. Epub 2005 Dec 1. PubMed PMID:16322356. See more on PubMed
  • Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF.Relationships between human serum resistin, inflammatory markers and insulinresistance. Int J Obes (Lond). 2005 Nov;29(11):1315-20. PubMed PMID: 16044175. See more on PubMed
  • Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokinewith potent proinflammatory properties. J Immunol. 2005 May 1;174(9):5789-95.PubMed PMID: 15843582. See more on PubMed
  • BOSANSKA L, PETRAK O, ZELINKA T, MRAZ M, WIDIMSKY J Jr, HALUZIK M. The effect of pheochromocytoma treatment on subclinical inflammation and endocrine function of adipose tissue. Physiol Res. 2009;58(3):319-25. Epub 2008 Jul 18. PubMed PMID:18637714. See more on PubMed
  • Broch M, Ramírez R, Auguet MT, Alcaide MJ, Aguilar C, Garcia-Espana A, RichartC. Macrophages are novel sites of expression and regulation of retinol bindingprotein-4 (RBP4). Physiol Res. 2010;59(2):299-303. Epub 2009 Jun 19. PubMed PMID:19537932. See more on PubMed
  • Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross-sectionalassociations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab. 2006 Jan;91(1):64-8. Epub 2005 Oct 25. PubMed PMID: 16249281. See more on PubMed
  • Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, LoboRA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur JEndocrinol. 2005 Mar;152(3):389-94. PubMed PMID: 15757855. See more on PubMed
  • Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA. Endothelial dysfunction in PCOS: role of obesity and adiposehormones. Am J Med. 2006 Apr;119(4):356.e1-6. PubMed PMID: 16564785. See more on PubMed
  • Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, Blaak EE. Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes:the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht(SLIM). Diabetes Care. 2007 Dec;30(12):3125-7. Epub 2007 Sep 21. PubMed PMID:17890316. See more on PubMed
  • Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I,Cortelazzi R, Beck-Peccoz P, Spada A. Maternal and foetal resistin andadiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol(Oxf). 2007 Mar;66(3):447-53. PubMed PMID: 17302882. See more on PubMed
  • da Silva TE, Costa-Silva M, Correa CG, Denardin G, Alencar MLA, Coelho MSPH,Muraro-Wildner L, Luiza-Bazzo M, González-Chica DA, Dantas-Correa EB,Narciso-Schiavon JL, Schiavon LL. Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis. Ann Hepatol. 2018 Mar 1;17(2):286-299. doi:10.5604/01.3001.0010.8659. PubMed PMID: 29469045. See more on PubMed
  • de Luis DA, Aller R, Gonzalez Sagrado M, Conde R, Izaola O, de la Fuente B.Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism)and their influence on anthropometric parameters and metabolic parameters under ahigh monounsaturated vs. high polyunsaturated fat hypocaloric diets. J NutrBiochem. 2013 Aug;24(8):1431-5. doi: 10.1016/j.jnutbio.2012.12.001. Epub 2013 Jan18. PubMed PMID: 23337343. See more on PubMed
  • de Luis DA, Aller R, Izaola O, de la Fuente B, Conde R, Sagrado MG, Primo D.Evaluation of weight loss and adipocytokines levels after two hypocaloric dietswith different macronutrient distribution in obese subjects with rs9939609 genevariant. Diabetes Metab Res Rev. 2012 Nov;28(8):663-8. doi: 10.1002/dmrr.2323.PubMed PMID: 22865603. See more on PubMed
  • de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Bellioo D, Conde R. Effectsof a low-fat versus a low-carbohydrate diet on adipocytokines in obese adults.Horm Res. 2007;67(6):296-300. Epub 2007 Feb 6. PubMed PMID: 17284923. See more on PubMed
  • de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, de la Fuente B,Perez Castrillon JL. Relationship of insulin resistance and adipocytokines onserum alanine aminotransferase in presurgical morbid obese patients. Eur Rev Med Pharmacol Sci. 2009 Nov-Dec;13(6):413-8. PubMed PMID: 20085121. See more on PubMed
  • de Luis DA, Aller R, Izaola O, Sagrado MG, Conde R, Bellido D. Influence ofinsulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch Med Res. 2008 Jan;39(1):110-4. Epub 2007 Sep 12. PubMedPMID: 18068003. See more on PubMed
  • de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R. Influence ofLys656Asn polymorphism of the leptin receptor gene on insulin resistance innondiabetic obese patients. J Diabetes Complications. 2008 May-Jun;22(3):199-204.doi: 10.1016/j.jdiacomp.2006.10.006. Epub 2008 Apr 16. PubMed PMID: 18413223. See more on PubMed
  • de Luis DA, González Sagrado M, Aller R, Izaola O, Conde R. Influence ofTrp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance,adipocytokines and weight loss secondary to two hypocaloric diets. Ann NutrMetab. 2009;54(2):104-10. doi: 10.1159/000209268. Epub 2009 Mar 19. PubMed PMID: 19295193. See more on PubMed
  • de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Primo D. Lack ofassociation of serum resistin levels with metabolic syndrome criteria in obesefemale patients. Clin Biochem. 2011 Nov;44(16):1280-3. doi:10.1016/j.clinbiochem.2011.09.002. Epub 2011 Sep 16. PubMed PMID: 21939645. See more on PubMed
  • De Luis DA, González Sagrado M, Conde R, Aller R, Izaola O. Resistin levelsand inflammatory markers in patients with morbid obesity. Nutr Hosp. 2010Jul-Aug;25(4):630-4. PubMed PMID: 20694300. See more on PubMed
  • de Luis DA, Izaola O, de la Fuente B, Primo D, Aller R. Association ofNeuropeptide Y Gene rs16147 Polymorphism with Cardiovascular Risk Factors,Adipokines, and Metabolic Syndrome in Patients with Obesity. J NutrigenetNutrigenomics. 2016;9(5-6):213-221. doi: 10.1159/000452131. Epub 2016 Oct 28.PubMed PMID: 27788523. See more on PubMed
  • de Luis DA, Izaola O, de la Fuente B, Primo D, Aller R. Polymorphism ofneuropeptide Y gene rs16147 modifies the response to a hypocaloric diet oncardiovascular risk biomarkers and adipokines. J Hum Nutr Diet. 2017Apr;30(2):159-165. doi: 10.1111/jhn.12406. Epub 2016 Sep 7. PubMed PMID:27599771. See more on PubMed
  • de Luis DA, Izaola O, de la Fuente B, Primo D, Fernandez Ovalle H, Romero E.rs1501299 Polymorphism in the Adiponectin Gene and Their Association with TotalAdiponectin Levels, Insulin Resistance and Metabolic Syndrome in Obese Subjects. Ann Nutr Metab. 2016;69(3-4):226-231. doi: 10.1159/000453401. Epub 2016 Dec 3.PubMed PMID: 27915341. See more on PubMed
  • de Luis DA, Izaola O, Primo D, Aller R. Effect of the rs1862513 variant ofresistin gene on insulin resistance and resistin levels after two hypocaloricdiets with different fat distribution in subjects with obesity. Eur Rev MedPharmacol Sci. 2018 Jun;22(12):3865-3872. doi: 10.26355/eurrev_201806_15271.PubMed PMID: 29949162. See more on PubMed
  • de Luis Roman D, de la Fuente RA, Sagrado MG, Izaola O, Vicente RC. Leptinreceptor Lys656Asn polymorphism is associated with decreased leptin response and weight loss secondary to a lifestyle modification in obese patients. Arch MedRes. 2006 Oct;37(7):854-9. PubMed PMID: 16971225. See more on PubMed
  • Derosa G, Fogari E, D'Angelo A, Cicero AF, Salvadeo SA, Ragonesi PD, FerrariI, Gravina A, Fassi R, Fogari R. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone. JClin Pharm Ther. 2007 Jun;32(3):261-8. PubMed PMID: 17489878. See more on PubMed
  • Derosa G, Maffioli P, Ferrari I, Palumbo I, Randazzo S, D'Angelo A, Cicero AF.Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients. J Pharm Pharm Sci. 2010;13(3):378-90. PubMed PMID:21092710. See more on PubMed
  • Derosa G, Maffioli P, Ferrari I, Palumbo I, Randazzo S, Fogari E, D'Angelo A, Cicero AF. Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients. Hypertens Res. 2011 Jan;34(1):145-51. doi: 10.1038/hr.2010.205. Epub 2010 Nov 25. PubMed PMID:21107327. See more on PubMed
  • Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, D'Angelo A, Palumbo I, Randazzo S, Cicero AF. Sibutramine and L-carnitine compared tosibutramine alone on insulin resistance in diabetic patients. Intern Med.2010;49(16):1717-25. Epub 2010 Aug 13. PubMed PMID: 20720348. See more on PubMed
  • Díaz-Soto G, de Luis DA, Conde-Vicente R, Izaola-Jauregui O, Ramos C, RomeroE. Beneficial effects of liraglutide on adipocytokines, insulin sensitivityparameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: aprospective study. Diabetes Res Clin Pract. 2014 Apr;104(1):92-6. doi:10.1016/j.diabres.2014.01.019. Epub 2014 Jan 25. PubMed PMID: 24530118. See more on PubMed
  • Dolezalová R, Haluzík MM, Bosanská L, Lacinová Z, Kasalová Z, Stulc T, HaluzíkM. Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunctionin patients with type 2 diabetes mellitus. Physiol Res. 2007;56(6):741-8. Epub2006 Nov 6. PubMed PMID: 17087601. See more on PubMed
  • Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D,Papezova H, Haluzik M. Changes of endocrine function of adipose tissue inanorexia nervosa: comparison of circulating levels versus subcutaneous mRNAexpression. Clin Endocrinol (Oxf). 2007 Nov;67(5):674-8. PubMed PMID: 17953628. See more on PubMed
  • Dolinková M, Dostálová I, Lacinová Z, Michalský D, Haluzíková D, Mráz M,Kasalický M, Haluzík M. The endocrine profile of subcutaneous and visceraladipose tissue of obese patients. Mol Cell Endocrinol. 2008 Sep10;291(1-2):63-70. doi: 10.1016/j.mce.2008.05.001. Epub 2008 May 9. PubMed PMID: 18565643. See more on PubMed
  • Dostálová I, Kaválková P, Haluzíková D, Lacinová Z, Mráz M, Papezová H,Haluzík M. Plasma concentrations of fibroblast growth factors 19 and 21 inpatients with anorexia nervosa. J Clin Endocrinol Metab. 2008 Sep;93(9):3627-32. doi: 10.1210/jc.2008-0746. Epub 2008 Jun 17. PubMed PMID: 18559909. See more on PubMed
  • Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Krsek M, Haluzík M. Plasma concentrations of fibroblast growthfactors 21 and 19 in patients with Cushing's syndrome. Physiol Res.2010;59(3):415-22. Epub 2009 Aug 12. PubMed PMID: 19681655. See more on PubMed
  • Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Kršek M, Haluzík M. Plasma concentrations of adipocyte fatty acidbinding protein in patients with Cushing's syndrome. Physiol Res.2010;59(6):963-71. Epub 2010 Jun 9. PubMed PMID: 20533865. See more on PubMed
  • Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD. Prognostic significance of plasma resistin levels inpatients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007Mar;378(1-2):78-85. Epub 2006 Nov 7. PubMed PMID: 17173885. See more on PubMed
  • Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley TH Jr, Kullo IJ.Association of plasma resistin with glomerular filtration rate and albuminuria inhypertensive adults. Hypertension. 2007 Oct;50(4):708-14. Epub 2007 Sep 4. PubMedPMID: 17785630. See more on PubMed
  • Escrivá F, Gavete ML, Fermín Y, Pérez C, Gallardo N, Alvarez C, Andrés A, Ros M, Carrascosa JM. Effect of age and moderate food restriction on insulinsensitivity in Wistar rats: role of adiposity. J Endocrinol. 2007Jul;194(1):131-41. PubMed PMID: 17592027. See more on PubMed
  • Faeh D, Minehira K, Schwarz JM, Periasamy R, Park S, Tappy L. Effect offructose overfeeding and fish oil administration on hepatic de novo lipogenesisand insulin sensitivity in healthy men. Diabetes. 2005 Jul;54(7):1907-13. Erratumin: Diabetes. 2006 Feb;55(2):563. Periasami, Raj [corrected to Periasamy, Raj];Seongsu, Park [corrected to Park, Seongsu]. PubMed PMID: 15983189. See more on PubMed
  • Filková M, Lisková M, Hulejová H, Haluzík M, Gatterová J, Pavelková A, PavelkaK, Gay S, Müller-Ladner U, Senolt L. Increased serum adiponectin levels in femalepatients with erosive compared with non-erosive osteoarthritis. Ann Rheum Dis.2009 Feb;68(2):295-6. doi: 10.1136/ard.2008.095737. PubMed PMID: 19139213. See more on PubMed
  • Fujinami A, Obayashi H, Ohta K, Ichimura T, Nishimura M, Matsui H, Kawahara Y,Yamazaki M, Ogata M, Hasegawa G, Nakamura N, Yoshikawa T, Nakano K, Ohta M.Enzyme-linked immunosorbent assay for circulating human resistin: resistinconcentrations in normal subjects and patients with type 2 diabetes. Clin ChimActa. 2004 Jan;339(1-2):57-63. PubMed PMID: 14687894. See more on PubMed
  • Furuhashi M, Ura N, Higashiura K, Murakami H, Shimamoto K. Circulatingresistin levels in essential hypertension. Clin Endocrinol (Oxf). 2003Oct;59(4):507-10. PubMed PMID: 14510915. See more on PubMed
  • Gambino R, Bo S, Musso G, Uberti B, Alemanno N, Ghione F, Guidi S, Tiozzo E,Chiusano V, Gentile L, Durazzo M, Pagano G, Cassader M. Microsomal triglyceridetransfer protein 493-T variant is associated with resistin levels and C-reactive protein. Clin Biochem. 2007 Nov;40(16-17):1219-24. Epub 2007 Aug 10. PubMed PMID:17825806. See more on PubMed
  • Garcia AL, Steiniger J, Reich SC, Weickert MO, Harsch I, Machowetz A, MohligM, Spranger J, Rudovich NN, Meuser F, Doerfer J, Katz N, Speth M, Zunft HJ,Pfeiffer AH, Koebnick C. Arabinoxylan fibre consumption improved glucosemetabolism, but did not affect serum adipokines in subjects with impaired glucosetolerance. Horm Metab Res. 2006 Nov;38(11):761-6. PubMed PMID: 17111305. See more on PubMed
  • Garcia JM, Sharafkhaneh H, Hirshkowitz M, Elkhatib R, Sharafkhaneh A. Weightand metabolic effects of CPAP in obstructive sleep apnea patients with obesity.Respir Res. 2011 Jun 15;12(1):80. doi: 10.1186/1465-9921-12-80. PubMed PMID:21676224; PubMed Central PMCID: PMC3146428. See more on PubMed
  • Gerber M, Boettner A, Seidel B, Lammert A, Bär J, Schuster E, Thiery J, Kiess W, Kratzsch J. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab. 2005Aug;90(8):4503-9. Epub 2005 May 31. PubMed PMID: 15928242. See more on PubMed
  • Gharibeh MY, Al Tawallbeh GM, Abboud MM, Radaideh A, Alhader AA, Khabour OF.Correlation of plasma resistin with obesity and insulin resistance in type 2diabetic patients. Diabetes Metab. 2010 Dec;36(6 Pt 1):443-9. doi:10.1016/j.diabet.2010.05.003. Epub 2010 Aug 23. PubMed PMID: 20739208. See more on PubMed
  • Gungor H, Kirilmaz B, Zorlu A, Oguz E, Ayik MF, Kumak F, Zoghi M. Association between resistin level and renal function in patients undergoing coronary artery bypass graft surgery. J Investig Med. 2012 Aug;60(6):883-7. doi:10.2310/JIM.0b013e31825459f9. PubMed PMID: 22534631. See more on PubMed
  • Gupta A, Gupta V, Singh AK, Tiwari S, Agrawal S, Natu SM, Agrawal CG, Negi MP,Pant AB. Interleukin-6 G-174C gene polymorphism and serum resistin levels inNorth Indian women: potential risk of metabolic syndrome. Hum Exp Toxicol. 2011Oct;30(10):1445-53. doi: 10.1177/0960327110393763. Epub 2010 Dec 22. PubMed PMID:21177727. See more on PubMed
  • Gupta V, Singh AK, Gupta V, Kumar S, Srivastava N, Jafar T, Pant AB.Association of circulating resistin with metabolic risk factors in Indian femaleshaving metabolic syndrome. Toxicol Int. 2011 Jul;18(2):168-72. doi:10.4103/0971-6580.84272. PubMed PMID: 21976825; PubMed Central PMCID: PMC3183627. See more on PubMed
  • Haluzíková D, Dostálová I, Kaválková P, Roubícek T, Mráz M, Papezová H,Haluzík M. Serum concentrations of adipocyte fatty acid binding protein inpatients with anorexia nervosa. Physiol Res. 2009;58(4):577-81. Epub 2008 Jul 25.PubMed PMID: 18657008. See more on PubMed
  • Haugen F, Ranheim T, Harsem NK, Lips E, Staff AC, Drevon CA. Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissuegene expression. Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E326-33. Epub2005 Sep 6. PubMed PMID: 16144822. See more on PubMed
  • Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H. Elevated serumC-reactive protein and free fatty acids among nondiabetic carriers of missensemutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy.Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):111-6. PubMed PMID: 12524233. See more on PubMed
  • Heilbronn LK, Rood J, Janderova L, Albu JB, Kelley DE, Ravussin E, Smith SR.Relationship between serum resistin concentrations and insulin resistance innonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab. 2004Apr;89(4):1844-8. PubMed PMID: 15070954. See more on PubMed
  • Hoefle G, Saely CH, Risch L, Koch L, Schmid F, Rein P, Aczél S, Berchtold S,Drexel H. Relationship between the adipose-tissue hormone resistin and coronaryartery disease. Clin Chim Acta. 2007 Nov-Dec;386(1-2):1-6. Epub 2007 Jul 13.PubMed PMID: 17706624. See more on PubMed
  • Housová J, Wilczek H, Haluzík MM, Kremen J, Krízová J, Haluzík M.Adipocyte-derived hormones in heroin addicts: the influence of methadonemaintenance treatment. Physiol Res. 2005;54(1):73-8. PubMed PMID: 15717844. See more on PubMed
  • Hui-Bing H, Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H,Ishibashi H, Eguchi K, Kimura H. Relationship between serum resistinconcentrations and inflammatory markers in patients with type 2 diabetesmellitus. Metabolism. 2006 Dec;55(12):1670-3. PubMed PMID: 17142142. See more on PubMed
  • Hulejová H, Levitová A, Kuklová M, Stochl J, Haluzík M, Pavelka K, VencovskýJ, Senolt L. No effect of physiotherapy on the serum levels of adipocytokines in patients with ankylosing spondylitis. Clin Rheumatol. 2012 Jan;31(1):67-71. doi: 10.1007/s10067-011-1773-7. Epub 2011 May 28. PubMed PMID: 21618078. See more on PubMed
  • Chalvatzas N, Dafopoulos K, Kosmas G, Kallitsaris A, Pournaras S, Messinis IE.Effect of ovarian hormones on serum adiponectin and resistin concentrations.Fertil Steril. 2009 Apr;91(4):1189-94. doi: 10.1016/j.fertnstert.2008.01.027.Epub 2008 Mar 5. PubMed PMID: 18325516. See more on PubMed
  • Chen D, Dong M, Fang Q, He J, Wang Z, Yang X. Alterations of serum resistin innormal pregnancy and pre-eclampsia. Clin Sci (Lond). 2005 Jan;108(1):81-4. PubMedPMID: 15377276. See more on PubMed
  • Chu MC, Cosper P, Nakhuda GS, Lobo RA. A comparison of oral and transdermalshort-term estrogen therapy in postmenopausal women with metabolic syndrome.Fertil Steril. 2006 Dec;86(6):1669-75. Epub 2006 Oct 30. PubMed PMID: 17074346. See more on PubMed
  • Chu MC, Cosper P, Orio F, Carmina E, Lobo RA. Insulin resistance inpostmenopausal women with metabolic syndrome and the measurements of adiponectin,leptin, resistin, and ghrelin. Am J Obstet Gynecol. 2006 Jan;194(1):100-4. PubMedPMID: 16389017. See more on PubMed
  • Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C. Adipokines and cardiometabolic profile in primaryhyperaldosteronism. J Clin Endocrinol Metab. 2010 May;95(5):2391-8. doi:10.1210/jc.2009-2204. Epub 2010 Mar 1. PubMed PMID: 20194710. See more on PubMed
  • Jørgensen SB, Honeyman J, Oakhill JS, Fazakerley D, Stöckli J, Kemp BE,Steinberg GR. Oligomeric resistin impairs insulin and AICAR-stimulated glucoseuptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am J PhysiolEndocrinol Metab. 2009 Jul;297(1):E57-66. doi: 10.1152/ajpendo.90744.2008. Epub2009 May 12. PubMed PMID: 19435854. See more on PubMed
  • Jurcovicová J, Stofková A, Skurlová M, Baculíková M, Zórad S, Stancíková M.Alterations in adipocyte glucose transporter GLUT4 and circulating adiponectinand visfatin in rat adjuvant induced arthritis. Gen Physiol Biophys. 2010Mar;29(1):79-84. PubMed PMID: 20371884. See more on PubMed
  • Kadoglou NP, Iliadis F, Liapis CD, Perrea D, Angelopoulou N, Alevizos M.Beneficial effects of combined treatment with rosiglitazone and exercise oncardiovascular risk factors in patients with type 2 diabetes. Diabetes Care. 2007Sep;30(9):2242-4. Epub 2007 Jun 22. PubMed PMID: 17586747. See more on PubMed
  • Kadoglou NP, Perrea D, Iliadis F, Angelopoulou N, Liapis C, Alevizos M.Exercise reduces resistin and inflammatory cytokines in patients with type 2diabetes. Diabetes Care. 2007 Mar;30(3):719-21. PubMed PMID: 17327348. See more on PubMed
  • Kakizaki S, Sohara N, Yamazaki Y, Horiguchi N, Kanda D, Kabeya K, Katakai K,Sato K, Takagi H, Mori M. Elevated plasma resistin concentrations in patientswith liver cirrhosis. J Gastroenterol Hepatol. 2008 Jan;23(1):73-7. doi:10.1111/j.1440-1746.2006.04757.x. PubMed PMID: 18171344. See more on PubMed
  • Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D. Increasedresistin blood levels are not associated with insulin resistance in patients withrenal disease. Am J Kidney Dis. 2003 Jul;42(1):62-6. PubMed PMID: 12830457. See more on PubMed
  • Kisacik B, Erol MF, Yilmaz G, Yilmaz FM, Maras Y, Kalyoncu U, Karadag O, KirazS, Ertenli I, Calguneri M. Resistin and visfatin: are they valuable enough to be the differential diagnosis in familial Mediterranean fever with acuteappendicitis? Clin Rheumatol. 2012 Feb;31(2):225-9. doi:10.1007/s10067-011-1806-2. Epub 2011 Jul 7. PubMed PMID: 21735058. See more on PubMed
  • Kleiblova P, Dostalova I, Bartlova M, Lacinova Z, Ticha I, Krejci V, Springer D, Kleibl Z, Haluzik M. Expression of adipokines and estrogen receptors inadipose tissue and placenta of patients with gestational diabetes mellitus. MolCell Endocrinol. 2010 Jan 15;314(1):150-6. doi: 10.1016/j.mce.2009.08.002. Epub2009 Aug 12. PubMed PMID: 19682537. See more on PubMed
  • Koebnick C, Wagner K, Garcia AL, Gruendel S, Lahmann PH, Weickert MO, MöhligM, Harsch IA, Einig C, Speth M, Katz N, Trippo U, Zunft HJ. Increase in serumresistin during weight loss in overweight subjects is related to lipidmetabolism. Int J Obes (Lond). 2006 Jul;30(7):1097-103. Epub 2006 Feb 14. PubMed PMID: 16477272. See more on PubMed
  • Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction andmetabolism and may predict survival of non-septic patients. Crit Care.2009;13(3):R95. doi: 10.1186/cc7925. Epub 2009 Jun 19. PubMed PMID: 19545363;PubMed Central PMCID: PMC2717467. See more on PubMed
  • Koch TC, Briviba K, Watzl B, Bub A, Barth SW. Obesity-related promotion ofaberrant crypt foci in DMH-treated obese Zucker rats correlates with dyslipidemiarather than hyperinsulinemia. Eur J Nutr. 2008 Apr;47(3):161-70. doi:10.1007/s00394-008-0711-1. Epub 2008 May 15. PubMed PMID: 18480976. See more on PubMed
  • Kopecký J Jr, Krusinová E, Klementová M, Kazdová L, Mlejnek P, Pravenec M,Hill M, Pelikánová T. Selected adipokines - plasma concentrations and adiposetissue expressions during 24-hour lipid infusion in healthy men. Physiol Res.2010;59(1):89-96. Epub 2009 Feb 27. PubMed PMID: 19249901. See more on PubMed
  • Kovacić D, Marinsek M, Gobec L, Lainscak M, Podbregar M. Effect of selectiveand non-selective beta-blockers on body weight, insulin resistance and leptinconcentration in chronic heart failure. Clin Res Cardiol. 2008 Jan;97(1):24-31.Epub 2007 Aug 17. PubMed PMID: 17694376. See more on PubMed
  • Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z,Haluzikova D, Bosanska L, Vokurka M, Svacina S, Haluzik M. Increased subcutaneousand epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J ClinEndocrinol Metab. 2006 Nov;91(11):4620-7. Epub 2006 Aug 8. PubMed PMID: 16895955. See more on PubMed
  • Krízová J, Dolinková M, Lacinová Z, Sulek S, Dolezalová R, Housová J,Krajícková J, Haluzíková D, Bosanská L, Papezová H, Haluzík M. Adiponectin andresistin gene polymorphisms in patients with anorexia nervosa and obesity and itsinfluence on metabolic phenotype. Physiol Res. 2008;57(4):539-46. Epub 2007 Jul26. PubMed PMID: 17705672. See more on PubMed
  • Krsek M, Silha JV, Jezková J, Hána V, Marek J, Weiss V, Stepán JJ, Murphy LJ. Adipokine levels in Cushing's syndrome; elevated resistin levels in femalepatients with Cushing's syndrome. Clin Endocrinol (Oxf). 2004 Mar;60(3):350-7.PubMed PMID: 15009001. See more on PubMed
  • Krusinová E, Klementová M, Kopecký J, Wohl P, Kazdová L, Mlejnek P, PravenecM, Hill M, Pelikánová T. Effect of acute hyperinsulinaemia with and withoutangiotensin II type 1 receptor blockade on resistin and adiponectinconcentrations and expressions in healthy subjects. Eur J Endocrinol. 2007Oct;157(4):443-9. PubMed PMID: 17893258. See more on PubMed
  • Lamounier-Zepter V, Bornstein SR, Kunes J, Zicha J, Krsek M, Ehrhart-BornsteinM, Ziegler CG, Kiessling A, Funk RH, Haluzik M. Adrenocortical changes andarterial hypertension in lipoatrophic A-ZIP/F-1 mice. Mol Cell Endocrinol. 2008Jan 2;280(1-2):39-46. Epub 2007 Oct 18. PubMed PMID: 18045774. See more on PubMed
  • Lee JH, Chan JL, Yiannakouris N, Kontogianni M, Estrada E, Seip R, Orlova C,Mantzoros CS. Circulating resistin levels are not associated with obesity orinsulin resistance in humans and are not regulated by fasting or leptinadministration: cross-sectional and interventional studies in normal,insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003Oct;88(10):4848-56. PubMed PMID: 14557464. See more on PubMed
  • Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. Aninflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004Nov;1(2):e45. Epub 2004 Nov 30. Review. PubMed PMID: 15578112; PubMed CentralPMCID: PMC529430. See more on PubMed
  • Lien LF, Haqq AM, Arlotto M, Slentz CA, Muehlbauer MJ, McMahon RL, Rochon J,Gallup D, Bain JR, Ilkayeva O, Wenner BR, Stevens RD, Millington DS, Muoio DM,Butler MD, Newgard CB, Svetkey LP. The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weightloss, maintenance, and regain. OMICS. 2009 Feb;13(1):21-35. doi:10.1089/omi.2008.0035. PubMed PMID: 19290809; PubMed Central PMCID: PMC2678563. See more on PubMed
  • Liu X, Zheng X, Su X, Tian W, Hu Y, Zhang Z. Plasma Resistin Levels inPatients with Acute Aortic Dissection: A Propensity Score-Matched ObservationalCase-Control Study. Med Sci Monit. 2018 Sep 13;24:6431-6437. doi:10.12659/MSM.909469. PubMed PMID: 30212440; PubMed Central PMCID: PMC6149239. See more on PubMed
  • Mangge H, Almer G, Haj-Yahya S, Grandits N, Gasser R, Pilz S, Möller R,Horejsi R. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles.Atherosclerosis. 2009 Mar;203(1):277-83. doi:10.1016/j.atherosclerosis.2008.06.013. Epub 2008 Jun 26. PubMed PMID: 18656877. See more on PubMed
  • Mangge H, Freytag F, Almer G, Weghuber D, Bauer-Denk C, Fuchs D. Serumneopterin is not increased in obese juveniles. J Obes. 2011;2011:946795. doi:10.1155/2011/946795. Epub 2011 Jan 12. PubMed PMID: 21274279; PubMed CentralPMCID: PMC3025381. See more on PubMed
  • Martos-Moreno GA, Barrios V, Argente J. Normative data for adiponectin,resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatricpopulation: relationship with sex steroids. Eur J Endocrinol. 2006Sep;155(3):429-34. PubMed PMID: 16914597. See more on PubMed
  • Megia A, Vendrell J, Gutierrez C, Sabaté M, Broch M, Fernández-Real JM, Simón I. Insulin sensitivity and resistin levels in gestational diabetes mellitus andafter parturition. Eur J Endocrinol. 2008 Feb;158(2):173-8. doi:10.1530/EJE-07-0671. PubMed PMID: 18230823. See more on PubMed
  • Meier U, Gressner AM. Endocrine regulation of energy metabolism: review ofpathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin,and resistin. Clin Chem. 2004 Sep;50(9):1511-25. Epub 2004 Jul 20. Review. PubMedPMID: 15265818. See more on PubMed
  • Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A, TrischittaV. Heritability of serum resistin and its genetic correlation with insulinresistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab.2006 Jul;91(7):2792-5. Epub 2006 May 2. PubMed PMID: 16670163. See more on PubMed
  • Menzaghi C, Marucci A, Antonucci A, De Bonis C, Ortega Moreno L, Salvemini L, Copetti M, Trischitta V, Di Paola R. Suggestive evidence of a multi-cytokineresistin pathway in humans and its role on cardiovascular events in high-riskindividuals. Sci Rep. 2017 Mar 14;7:44337. doi: 10.1038/srep44337. PubMed PMID:28290549; PubMed Central PMCID: PMC5349527. See more on PubMed
  • Menzaghi C, Salvemini L, Fini G, Thompson R, Mangiacotti D, Di Paola R, MoriniE, Giorelli M, De Bonis C, De Cosmo S, Doria A, Trischitta V. Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals.PLoS One. 2012;7(6):e38414. doi: 10.1371/journal.pone.0038414. Epub 2012 Jun 12. PubMed PMID: 22701635; PubMed Central PMCID: PMC3373540. See more on PubMed
  • Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation andinsulin resistance in patients with type 2 diabetes mellitus. Scand J Clin LabInvest. 2007;67(2):215-25. PubMed PMID: 17366001. See more on PubMed
  • Mojiminiyi OA, Al Mulla F, Abdella NA. Which obesity index best explains thelink between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract. 2009;18(2):123-9. doi:10.1159/000189810. Epub 2009 Feb 10. PubMed PMID: 19204431. See more on PubMed
  • Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S,Ovalle K, Moussa A, Mantzoros CS. Effect of lifestyle modification on adipokinelevels in obese subjects with insulin resistance. Obes Res. 2003Sep;11(9):1048-54. PubMed PMID: 12972674. See more on PubMed
  • Musso G, Gambino R, Bo S, Uberti B, Biroli G, Pagano G, Cassader M. Shouldnonalcoholic fatty liver disease be included in the definition of metabolicsyndrome? A cross-sectional comparison with Adult Treatment Panel III criteria innonobese nondiabetic subjects. Diabetes Care. 2008 Mar;31(3):562-8. Epub 2007 Dec4. PubMed PMID: 18056890. See more on PubMed
  • Musso G, Gambino R, De Michieli F, Biroli G, Premoli A, Pagano G, Bo S,Durazzo M, Cassader M. Nitrosative stress predicts the presence and severity ofnonalcoholic fatty liver at different stages of the development of insulinresistance and metabolic syndrome: possible role of vitamin A intake. Am J ClinNutr. 2007 Sep;86(3):661-71. PubMed PMID: 17823431. See more on PubMed
  • Musso G, Gambino R, De Michieli F, Durazzo M, Pagano G, Cassader M.Adiponectin gene polymorphisms modulate acute adiponectin response to dietaryfat: Possible pathogenetic role in NASH. Hepatology. 2008 Apr;47(4):1167-77. doi:10.1002/hep.22142. PubMed PMID: 18311774. See more on PubMed
  • Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, Pacini G, DeMichieli F, Rabbione L, Premoli A, Cassader M, Pagano G. Adipokines in NASH:postprandial lipid metabolism as a link between adiponectin and liver disease.Hepatology. 2005 Nov;42(5):1175-83. PubMed PMID: 16231364. See more on PubMed
  • Musso G, Gambino R, Pacini G, De Michieli F, Cassader M. Prolonged saturatedfat-induced, glucose-dependent insulinotropic polypeptide elevation is associatedwith adipokine imbalance and liver injury in nonalcoholic steatohepatitis:dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am J ClinNutr. 2009 Feb;89(2):558-67. doi: 10.3945/ajcn.2008.26720. Epub 2009 Jan 13.PubMed PMID: 19141695. See more on PubMed
  • Mutakin, Meiliana A, Wijaya A, Kobayashi K, Yamazaki C, Kameo S, Nakazawa M,Koyama H. Association between selenium nutritional status and metabolic riskfactors in men with visceral obesity. J Trace Elem Med Biol. 2013Apr;27(2):112-6. doi: 10.1016/j.jtemb.2012.09.006. Epub 2012 Nov 28. PubMed PMID:23199701. See more on PubMed
  • Nagaev I, Bokarewa M, Tarkowski A, Smith U. Human resistin is a systemicimmune-derived proinflammatory cytokine targeting both leukocytes and adipocytes.PLoS One. 2006 Dec 20;1:e31. PubMed PMID: 17183659; PubMed Central PMCID:PMC1762367. See more on PubMed
  • Nakajima H, Nakajima K, Tarutani M, Morishige R, Sano S. Kinetics ofcirculating Th17 cytokines and adipokines in psoriasis patients. Arch DermatolRes. 2011 Aug;303(6):451-5. doi: 10.1007/s00403-011-1159-3. Epub 2011 Jun 17.PubMed PMID: 21681565; PubMed Central PMCID: PMC3140918. See more on PubMed
  • Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, ShahSH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WS Jr,Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP. Abranched-chain amino acid-related metabolic signature that differentiates obeseand lean humans and contributes to insulin resistance. Cell Metab. 2009Apr;9(4):311-26. doi: 10.1016/j.cmet.2009.02.002. Erratum in: Cell Metab. 2009Jun;9(6):565-6. PubMed PMID: 19356713; PubMed Central PMCID: PMC3640280. See more on PubMed
  • Nüsken KD, Kratzsch J, Wienholz V, Stöhr W, Rascher W, Dötsch J. Circulatingresistin concentrations in children depend on renal function. Nephrol DialTransplant. 2006 Jan;21(1):107-12. Epub 2005 Sep 6. PubMed PMID: 16144855. See more on PubMed
  • Nyström T, Nygren A, Sjöholm A. Increased levels of tumour necrosisfactor-alpha (TNF-alpha) in patients with Type II diabetes mellitus aftermyocardial infarction are related to endothelial dysfunction. Clin Sci (Lond).2006 Jun;110(6):673-81. PubMed PMID: 16466346. See more on PubMed
  • Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M, Nakamura H,Ohsuzu F. Associations between serum resistin levels and insulin resistance,inflammation, and coronary artery disease. J Am Coll Cardiol. 2005 Jul19;46(2):379-80. PubMed PMID: 16022972. See more on PubMed
  • Ozkok A, Atas R, Cinar SA, Yilmaz A, Aktas E, Deniz G, Yildiz A. CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysispatients. BMC Nephrol. 2017 Jul 26;18(1):250. doi: 10.1186/s12882-017-0663-x.PubMed PMID: 28747175; PubMed Central PMCID: PMC5530565. See more on PubMed
  • Paduszyńska A, Sakowicz A, Banach M, Maciejewski M, Dąbrowa M,Bielecka-Dąbrowa A. Cardioprotective properties of leptin in patients withexcessive body mass. Ir J Med Sci. 2020 Mar 20. doi: 10.1007/s11845-020-02211-9. [Epub ahead of print] PubMed PMID: 32198598. See more on PubMed
  • Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M,Fanin E, Andrighetto G, Federspil G, Vettor R. Increased serum resistin in adultswith prader-willi syndrome is related to obesity and not to insulin resistance. JClin Endocrinol Metab. 2005 Jul;90(7):4335-40. Epub 2005 May 3. PubMed PMID:15870134. See more on PubMed
  • Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, FaggianD, Mussap M, Plebani M, Avellini C, Federspil G, Sechi LA, Vettor R. Increasedserum resistin in nonalcoholic fatty liver disease is related to liver diseaseseverity and not to insulin resistance. J Clin Endocrinol Metab. 2006Mar;91(3):1081-6. Epub 2006 Jan 4. PubMed PMID: 16394091. See more on PubMed
  • Pamuk GE, Demir M, Harmandar F, Yesil Y, Turgut B, Vural O. Leptin andresistin levels in serum of patients with hematologic malignancies: correlationwith clinical characteristics. Exp Oncol. 2006 Sep;28(3):241-4. PubMed PMID:17080020. See more on PubMed
  • Papadopoulos DP, Perrea D, Thomopoulos C, Sanidas E, Daskalaki M, PapazachouU, Votteas V, Makris T. Masked hypertension and atherogenesis: the impact onadiponectin and resistin plasma levels. J Clin Hypertens (Greenwich). 2009Feb;11(2):61-5. doi: 10.1111/j.1751-7176.2008.00070.x. PubMed PMID: 19222669. See more on PubMed
  • Park JH, Lee SG, Jeon YK, Park EK, Suh YS, Kim HO. Relationship between serum adipokine levels and radiographic progression in patients with ankylosingspondylitis: A preliminary 2-year longitudinal study. Medicine (Baltimore). 2017 Aug;96(33):e7854. doi: 10.1097/MD.0000000000007854. PubMed PMID: 28816988; PubMedCentral PMCID: PMC5571725. See more on PubMed
  • Paul G, Schäffler A, Neumeier M, Fürst A, Bataillle F, Buechler C,Müller-Ladner U, Schölmerich J, Rogler G, Herfarth H. Profiling adipocytokinesecretion from creeping fat in Crohn's disease. Inflamm Bowel Dis. 2006Jun;12(6):471-7. PubMed PMID: 16775490. See more on PubMed
  • Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, EspositoA, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, ChiumelloG, Luzi L. Insulin resistance and whole body energy homeostasis in obeseadolescents with fatty liver disease. Am J Physiol Endocrinol Metab. 2006Oct;291(4):E697-703. Epub 2006 May 9. PubMed PMID: 16684857. See more on PubMed
  • Perseghin G, Burska A, Lattuada G, Alberti G, Costantino F, Ragogna F,Oggionni S, Scollo A, Terruzzi I, Luzi L. Increased serum resistin in eliteendurance athletes with high insulin sensitivity. Diabetologia. 2006Aug;49(8):1893-900. Epub 2006 May 10. PubMed PMID: 16685503. See more on PubMed
  • Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, ScifoP, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L. Reduced intrahepaticfat content is associated with increased whole-body lipid oxidation in patientswith type 1 diabetes. Diabetologia. 2005 Dec;48(12):2615-21. Epub 2005 Nov 1.PubMed PMID: 16261312. See more on PubMed
  • Perseghin G, Ntali G, De Cobelli F, Lattuada G, Esposito A, Belloni E, Canu T,Costantino F, Ragogna F, Scifo P, Del Maschio A, Luzi L. Abnormal leftventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care. 2007Jun;30(6):1520-6. Epub 2007 Mar 23. PubMed PMID: 17384336. See more on PubMed
  • Pilz S, Horejsi R, Möller R, Almer G, Scharnagl H, Stojakovic T, Dimitrova R, Weihrauch G, Borkenstein M, Maerz W, Schauenstein K, Mangge H. Earlyatherosclerosis in obese juveniles is associated with low serum levels ofadiponectin. J Clin Endocrinol Metab. 2005 Aug;90(8):4792-6. Epub 2005 May 31.PubMed PMID: 15928248. See more on PubMed
  • Pilz S, Weihrauch G, Seelhorst U, Wellnitz B, Winkelmann BR, Boehm BO, März W.Implications of resistin plasma levels in subjects undergoing coronaryangiography. Clin Endocrinol (Oxf). 2007 Mar;66(3):380-6. PubMed PMID: 17302872. See more on PubMed
  • Pirola CJ, Gianotti TF, Burgueño AL, Rey-Funes M, Loidl CF, Mallardi P,Martino JS, Castaño GO, Sookoian S. Epigenetic modification of livermitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut. 2013 Sep;62(9):1356-63. doi: 10.1136/gutjnl-2012-302962. Epub2012 Aug 9. PubMed PMID: 22879518. See more on PubMed
  • Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H,Windler E. Association of plasma resistin levels with coronary heart disease inwomen. Obes Res. 2005 Oct;13(10):1764-71. PubMed PMID: 16286524. See more on PubMed
  • Pravenec M, Kazdová L, Cahová M, Landa V, Zídek V, Mlejnek P, Simáková M, WangJ, Qi N, Kurtz TW. Fat-specific transgenic expression of resistin in thespontaneously hypertensive rat impairs fatty acid re-esterification. Int J Obes(Lond). 2006 Jul;30(7):1157-9. Epub 2006 Jan 24. PubMed PMID: 16432541. See more on PubMed
  • Qi Q, Menzaghi C, Smith S, Liang L, de Rekeneire N, Garcia ME, Lohman KK,Miljkovic I, Strotmeyer ES, Cummings SR, Kanaya AM, Tylavsky FA, Satterfield S,Ding J, Rimm EB, Trischitta V, Hu FB, Liu Y, Qi L. Genome-wide associationanalysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistinlevels. Hum Mol Genet. 2012 Nov 1;21(21):4774-80. doi: 10.1093/hmg/dds300. Epub2012 Jul 26. PubMed PMID: 22843503; PubMed Central PMCID: PMC3471394. See more on PubMed
  • Rae C, Graham A. Human resistin promotes macrophage lipid accumulation.Diabetologia. 2006 May;49(5):1112-4. Epub 2006 Mar 11. PubMed PMID: 16532325. See more on PubMed
  • Rank M, Siegrist M, Wilks DC, Langhof H, Wolfarth B, Haller B, Koenig W, HalleM. The cardio-metabolic risk of moderate and severe obesity in children andadolescents. J Pediatr. 2013 Jul;163(1):137-42. doi: 10.1016/j.jpeds.2013.01.020.Epub 2013 Feb 20. PubMed PMID: 23434121. See more on PubMed
  • Redondo C, Burke BJ, Findlay JB. The retinol-binding protein system: apotential paradigm for steroid-binding globulins? Horm Metab Res. 2006Apr;38(4):269-78. Review. PubMed PMID: 16700009. See more on PubMed
  • Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is aninflammatory marker of atherosclerosis in humans. Circulation. 2005 Feb22;111(7):932-9. Epub 2005 Feb 14. PubMed PMID: 15710760. See more on PubMed
  • Rezaei Esfahrood Z, Vardian Tehrani S, Yadegari Z, Shams B, Dehnavi F, ShamsN. Evaluation of Resistin Levels in Saliva of Patients with Chronic Periodontitisand Healthy Subjects. Chin J Dent Res. 2018;21(2):143-146. doi:10.3290/j.cjdr.a40441. PubMed PMID: 29808178. See more on PubMed
  • Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S,Drexel H. Relationship between glomerular filtration rate and the adipokinesadiponectin, resistin and leptin in coronary patients with predominantly normalor mildly impaired renal function. Clin Chim Acta. 2007 Feb;376(1-2):108-13. Epub2006 Jul 29. PubMed PMID: 16956602. See more on PubMed
  • Roderburg C, Koch A, Tacke F, Nieuwenhuijsen L, Bruensing J, Vargas CardenasD, Kreggenwinkel K, Vucur M, Koppe C, Jungebluth P, Seikrit C, Luedde M,Trautwein C, Luedde T. Serum concentrations of A Proliferation-Inducing Ligand(APRIL) are elevated in sepsis and predict mortality in critically ill patients. J Crit Care. 2013 Oct;28(5):882.e1-11. doi: 10.1016/j.jcrc.2012.11.007. Epub 2013Jan 20. PubMed PMID: 23337484. See more on PubMed
  • Rozmilowska I, Czyzewski D, Mazur B, Adamczyk-Sowa M. What is the role ofadipokines in myasthenia gravis? Ther Clin Risk Manag. 2018 Aug 28;14:1515-1525. doi: 10.2147/TCRM.S163966. eCollection 2018. PubMed PMID: 30214215; PubMedCentral PMCID: PMC6118871. See more on PubMed
  • Rubino E, Vacca A, Govone F, Gai A, Boschi S, Zucca M, De Martino P, GentileS, Pinessi L, Rainero I. Investigating the role of adipokines in chronicmigraine. Cephalalgia. 2017 Oct;37(11):1067-1073. doi: 10.1177/0333102416665871. Epub 2016 Aug 22. PubMed PMID: 27553954. See more on PubMed
  • Rzepka R, Dołęgowska B, Rajewska A, Sałata D, Budkowska M, Kwiatkowski S,Torbé A. Diagnostic Potential of Evaluation of SDF-1α and sRAGE Levels inThreatened Premature Labor. Biomed Res Int. 2016;2016:2719460. doi:10.1155/2016/2719460. Epub 2016 Jul 31. PubMed PMID: 27556030; PubMed CentralPMCID: PMC4983339. See more on PubMed
  • Sadashiv, Tiwari S, Paul BN, Kumar S, Chandra A, Dhananjai S, Negi MP. Overexpression of resistin in adipose tissue of the obese induces insulin resistance.World J Diabetes. 2012 Jul 15;3(7):135-41. doi: 10.4239/wjd.v3.i7.135. PubMedPMID: 22816026; PubMed Central PMCID: PMC3399912. See more on PubMed
  • Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, Kiyohara Y,Iida M, Yamashita Y. Serum levels of resistin and adiponectin in women withperiodontitis: the Hisayama study. J Dent Res. 2008 Apr;87(4):319-22. PubMedPMID: 18362311. See more on PubMed
  • Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007 Apr;66(4):458-63. Epub 2006Oct 13. PubMed PMID: 17040961; PubMed Central PMCID: PMC1856051. See more on PubMed
  • Shaw KA, Hennebold JD, Edelman AB. Effect of a combined estrogen andprogesterone oral contraceptive on circulating adipocytokines adiponectin,resistin and DLK-1 in normal and obese female rhesus monkeys. Contraception. 2013Jul;88(1):177-82. doi: 10.1016/j.contraception.2012.10.029. Epub 2012 Dec 4.PubMed PMID: 23218850; PubMed Central PMCID: PMC3919957. See more on PubMed
  • Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulatingadiponectin and resistin levels in relation to metabolic factors, inflammatorymarkers, and vascular reactivity in diabetic patients and subjects at risk fordiabetes. Diabetes Care. 2004 Oct;27(10):2450-7. PubMed PMID: 15451915. See more on PubMed
  • Schäffler A, Büchler C, Müller-Ladner U, Herfarth H, Ehling A, Paul G,Schölmerich J, Zietz B. Identification of variables influencing resistin serumlevels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res. 2004Oct;36(10):702-7. PubMed PMID: 15523596. See more on PubMed
  • Schäffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Schölmerich J,Müller-Ladner U, Gay S. Adipocytokines in synovial fluid. JAMA. 2003 Oct1;290(13):1709-10. Erratum in: JAMA. 2004 Feb 4;291(5):563. PubMed PMID:14519703. See more on PubMed
  • Schäffler A, Landfried K, Völk M, Fürst A, Büchler C, Schölmerich J, Herfarth H. Potential of adipocytokines in predicting peripancreatic necrosis and severityin acute pancreatitis: pilot study. J Gastroenterol Hepatol. 2007Mar;22(3):326-34. PubMed PMID: 17295762. See more on PubMed
  • Silha JV, Krsek M, Hana V, Marek J, Jezkova J, Weiss V, Murphy LJ.Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack ofcorrelation with insulin resistance. Clin Endocrinol (Oxf). 2003Jun;58(6):736-42. PubMed PMID: 12780751. See more on PubMed
  • Silha JV, Krsek M, Skrha J, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin,leptin and adiponectin levels in non-diabetic and diabetic obese subjects. DiabetMed. 2004 May;21(5):497-9. PubMed PMID: 15089799. See more on PubMed
  • Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasmaresistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003 Oct;149(4):331-5. PubMed PMID:14514348. See more on PubMed
  • Sopasakis VR, Nagaev I, Smith U. Cytokine release from adipose tissue ofnonobese individuals. Int J Obes (Lond). 2005 Sep;29(9):1144-7. PubMed PMID:15917841. See more on PubMed
  • Spanos N, Tziomalos K, Macut D, Koiou E, Kandaraki EA, Delkos D, Tsourdi E,Panidis D. Adipokines, insulin resistance and hyperandrogenemia in obese patientswith polycystic ovary syndrome: cross-sectional correlations and the effects ofweight loss. Obes Facts. 2012;5(4):495-504. doi: 10.1159/000341579. Epub 2012 Jul23. PubMed PMID: 22854419. See more on PubMed
  • Stejskal D, Adamovská S, Bartek J, Juráková R, Prosková J. Resistin -concentrations in persons with type 2 diabetes mellitus and in individuals withacute inflammatory disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Nov;147(1):63-9. PubMed PMID: 15034607. See more on PubMed
  • Stejskal D, Prosková J, Adamovská S, Juráková R, Bartek J. Preliminaryexperience with resistin assessment in common population. Biomed Pap Med Fac UnivPalacky Olomouc Czech Repub. 2002 Dec;146(2):47-9. PubMed PMID: 12572895. See more on PubMed
  • Stejskal D, Růzicka V, Adamovská S, Juráková R, Prosková J, Jedelský L, BartekJ. Adiponectin concentrations as a criterion of metabolic control in persons withtype 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.2003 Dec;147(2):167-72. PubMed PMID: 15037898. See more on PubMed
  • Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J,Norrby-Teglund A, Treutiger CJ. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007Jun;35(6):1536-42. PubMed PMID: 17452927. See more on PubMed
  • Svensson J, Herlitz H, Lundberg PA, Johannsson G. Adiponectin, leptin, anderythrocyte sodium/lithium countertransport activity, but not resistin, arerelated to glucose metabolism in growth hormone-deficient adults. J ClinEndocrinol Metab. 2005 Apr;90(4):2290-6. Epub 2005 Jan 5. PubMed PMID: 15634721. See more on PubMed
  • Szewczyk-Golec K, Rajewski P, Gackowski M, Mila-Kierzenkowska C, Wesołowski R,Sutkowy P, Pawłowska M, Woźniak A. Melatonin Supplementation Lowers OxidativeStress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.Oxid Med Cell Longev. 2017;2017:8494107. doi: 10.1155/2017/8494107. Epub 2017 Sep21. PubMed PMID: 29142618; PubMed Central PMCID: PMC5632922. See more on PubMed
  • Šenolt L, Kuklová M, Cerezo LA, Hulejová H, Filková M, Bošanská L, Pecha O,Pavelka K, Haluzík M, Vencovský J. Adipokine profile is modulated in subcutaneousadipose tissue by TNFα inhibitors in patients with rheumatoid arthritis. AnnRheum Dis. 2011 Nov;70(11):2054-6. doi: 10.1136/ard.2011.152603. Epub 2011 May27. PubMed PMID: 21622768. See more on PubMed
  • Tat RM, Golea A, Vesa ŞC, Ionescu D. Resistin-Can it be a new early marker forprognosis in patients who survive after a cardiac arrest? A pilot study. PLoSOne. 2019 Jan 16;14(1):e0210666. doi: 10.1371/journal.pone.0210666. eCollection2019. PubMed PMID: 30650128; PubMed Central PMCID: PMC6334922. See more on PubMed
  • Tauman R, Serpero LD, Capdevila OS, O'Brien LM, Goldbart AD, Kheirandish-GozalL, Gozal D. Adipokines in children with sleep disordered breathing. Sleep. 2007Apr;30(4):443-9. PubMed PMID: 17520788. See more on PubMed
  • Tejero ME, Freeland-Graves JH, Proffitt JM, Peebles KW, Cai G, Cole SA,Comuzzie AG. Adiponectin but not resistin is associated with insulinresistance-related phenotypes in baboons. Obes Res. 2004 May;12(5):871-7. PubMed PMID: 15166309. See more on PubMed
  • Terra X, Auguet T, Porras JA, Quintero Y, Aguilar C, Luna AM, Hernández M,Sabench F, del Castillo D, Richart C. Anti-inflammatory profile of FTO geneexpression in adipose tissues from morbidly obese women. Cell Physiol Biochem.2010;26(6):1041-50. doi: 10.1159/000323979. Epub 2011 Jan 4. PubMed PMID:21220935. See more on PubMed
  • Terra X, Quintero Y, Auguet T, Porras JA, Hernández M, Sabench F, Aguilar C,Luna AM, Del Castillo D, Richart C. FABP 4 is associated with inflammatorymarkers and metabolic syndrome in morbidly obese women. Eur J Endocrinol. 2011Apr;164(4):539-47. doi: 10.1530/EJE-10-1195. Epub 2011 Jan 21. PubMed PMID:21257725. See more on PubMed
  • Thomopoulos C, Daskalaki M, Papazachou O, Rodolakis N, Bratsas A, PapadopoulosDP, Papavasileiou MV, Perrea D, Makris T. Association of resistin and adiponectinwith different clinical blood pressure phenotypes. J Hum Hypertens. 2011Jan;25(1):38-46. doi: 10.1038/jhh.2010.22. Epub 2010 Mar 4. PubMed PMID:20200551. See more on PubMed
  • Trachta P, Dostálová I, Haluzíková D, Kasalický M, Kaválková P, Drápalová J,Urbanová M, Lacinová Z, Mráz M, Haluzík M. Laparoscopic sleeve gastrectomyameliorates mRNA expression of inflammation-related genes in subcutaneous adiposetissue but not in peripheral monocytes of obese patients. Mol Cell Endocrinol.2014 Mar 5;383(1-2):96-102. doi: 10.1016/j.mce.2013.11.013. Epub 2013 Nov 27.PubMed PMID: 24291610. See more on PubMed
  • Turnbull CD, Rossi VA, Santer P, Schwarz EI, Stradling JR, Petousi N, KohlerM. Effect of OSA on hypoxic and inflammatory markers during CPAP withdrawal:Further evidence from three randomized control trials. Respirology. 2017May;22(4):793-799. doi: 10.1111/resp.12946. Epub 2016 Nov 18. PubMed PMID:27860068. See more on PubMed
  • Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B,Guercio G, Diana G, Ciaccio M, Licata G, Pinto A. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations withclinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010 Sep13;9:50. doi: 10.1186/1475-2840-9-50. PubMed PMID: 20836881; PubMed CentralPMCID: PMC2946274. See more on PubMed
  • Verhaeghe J, van Bree R, Lambin S, Caluwaerts S. Adipokine profile andC-reactive protein in pregnancy: effects of glucose challenge response versusbody mass index. J Soc Gynecol Investig. 2005 Jul;12(5):330-4. PubMed PMID:15979544. See more on PubMed
  • Vilarrasa N, Vendrell J, Maravall J, Broch M, Estepa A, Megia A, Soler J,Simón I, Richart C, Gómez JM. Distribution and determinants of adiponectin,resistin and ghrelin in a randomly selected healthy population. Clin Endocrinol(Oxf). 2005 Sep;63(3):329-35. PubMed PMID: 16117822. See more on PubMed
  • Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA. Highserum resistin is associated with an increase in adiposity but not a worsening ofinsulin resistance in Pima Indians. Diabetes. 2004 May;53(5):1279-84. Erratum in:Diabetes. 2004 Sep;53(9):2518. Volarova de Courten, B [corrected to Vozarova deCourten, B]. PubMed PMID: 15111497. See more on PubMed
  • Weikert C, Westphal S, Berger K, Dierkes J, Möhlig M, Spranger J, Rimm EB,Willich SN, Boeing H, Pischon T. Plasma resistin levels and risk of myocardialinfarction and ischemic stroke. J Clin Endocrinol Metab. 2008 Jul;93(7):2647-53. doi: 10.1210/jc.2007-2735. Epub 2008 May 6. PubMed PMID: 18460562. See more on PubMed
  • Weikert C, Westphal S, Luley C, Willich SN, Boeing H, Pischon T.Within-subject variation of plasma resistin levels over a 1-year period. ClinChem Lab Med. 2007;45(7):899-902. PubMed PMID: 17617035. See more on PubMed
  • Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Adipokines and treatmentwith niacin. Metabolism. 2006 Oct;55(10):1283-5. PubMed PMID: 16979396. See more on PubMed
  • Westphal S, Borucki K, Taneva E, Makarova R, Luley C. Extended-release niacin raises adiponectin and leptin. Atherosclerosis. 2007 Aug;193(2):361-5. Epub 2006 Aug 2. PubMed PMID: 16887123. See more on PubMed
  • Wohl P, Krusinová E, Hill M, Kratochvílová S, Zídková K, Kopecký J, NeskudlaT, Pravenec M, Klementová M, Vrbíková J, Wohl P, Mlejnek P, Pelikánová T. Effect of telmisartan on selected adipokines, insulin sensitivity, and substrateutilization during insulin-stimulated conditions in patients with metabolicsyndrome and impaired fasting glucose. Eur J Endocrinol. 2010 Oct;163(4):573-83. doi: 10.1530/EJE-10-0436. Epub 2010 Jul 14. PubMed PMID: 20630944. See more on PubMed
  • Wójcik K, Jabłonowska E, Omulecka A, Piekarska A. Insulin resistance,adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.World J Gastroenterol. 2014 Aug 14;20(30):10449-56. doi:10.3748/wjg.v20.i30.10449. PubMed PMID: 25132761; PubMed Central PMCID:PMC4130852. See more on PubMed
  • Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasmaleptin, soluble leptin receptor, adiponectin and resistin levels in healthyvolunteers. Clin Endocrinol (Oxf). 2004 Sep;61(3):332-8. PubMed PMID: 15355449. See more on PubMed
  • Wong SP, Huda M, English P, Bargiota A, Wilding JP, Johnson A, Corrall R,Pinkney JH. Adipokines and the insulin resistance syndrome in familial partiallipodystrophy caused by a mutation in lamin A/C. Diabetologia. 2005Dec;48(12):2641-9. Epub 2005 Nov 17. Erratum in: Diabetologia. 2019 Jan 29;:.PubMed PMID: 16320084. See more on PubMed
  • Yannakoulia M, Yiannakouris N, Blüher S, Matalas AL, Klimis-Zacas D, MantzorosCS. Body fat mass and macronutrient intake in relation to circulating solubleleptin receptor, free leptin index, adiponectin, and resistin concentrations inhealthy humans. J Clin Endocrinol Metab. 2003 Apr;88(4):1730-6. PubMed PMID:12679465. See more on PubMed
  • Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, Rafiq N,Goodman Z, Chandhoke V, Baranova A. A novel diagnostic biomarker panel forobesity-related nonalcoholic steatohepatitis (NASH). Obes Surg. 2008Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24. PubMed PMID:18500507. See more on PubMed
  • Zayani N, Hamdouni H, Boumaiza I, Achour O, Neffati F, Omezzine A, Najjar MF, Bouslama A. Resistin polymorphims, plasma resistin levels and obesity in Tunisianvolunteers. J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22227. Epub 2017Apr 10. PubMed PMID: 28393393. See more on PubMed
  • Zhou L, Sell H, Eckardt K, Yang Z, Eckel J. Conditioned medium obtained fromin vitro differentiated adipocytes and resistin induce insulin resistance inhuman hepatocytes. FEBS Lett. 2007 Sep 4;581(22):4303-8. Epub 2007 Aug 10. PubMedPMID: 17716671. See more on PubMed
Summary References (21)

References to Resistin

  • Banerjee RR, Lazar MA. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem. 2001 Jul 13;276 (28):25970-3
  • Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005 May 1;174 (9):5789-95
  • Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2001 Nov 9;288 (4):1027-31
  • Fasshauer M, Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia. 2003 Dec;46 (12):1594-603
  • Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M, Chen R. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol. 2004 Jun;150 (6):885-92
  • Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA:. Mechanisms Regulating Adipocyte Expression of Resistin. J Biol Chem. 277, 19754-19761, (2002) .
  • Juan CC, Au LC, Fang VS, Kang SF, Ko YH, Kuo SF, Hsu YP, Kwok CF, Ho LT. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun. 2001 Dec 21;289 (5):1328-33
  • Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004 Jun;89 (6):2548-56
  • Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001 Apr 6;276 (14):11252-6
  • Maebuchi M, Machidori M, Urade R, Ogawa T, Moriyama T:. Low resistin levels in adipose tissues and serum high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Archiv Biochem Biophys. 416, 164-170 (2003) .
  • Malo E, Ukkola O, Jokela M, Moilanen L, Kahonen M, Nieminen MS, Salomaa V, Jula A, Kesaniemi YA. Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey. Metab Syndr Relat Disord. 2011 Jun;9 (3):203-10
  • Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004 Sep;50 (9):1511-25
  • Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res. 2002 Nov;10 (11):1095-103
  • Nogueiras R, Gallego R, Gualillo O, Caminos JE, Garcia-Caballero T, Casanueva FF, Dieguez C. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 2003 Jul 31;548 (1-3):21-7
  • Pravenec M, Kazdová L, Landa V, Zídek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW:. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 278, 45209-45215, (2001) .
  • Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003 Jan;111 (2):225-30
  • Sadashiv, Tiwari S, Paul BN, Kumar S, Chandra A, Dhananjai S, Negi MP. Over expression of resistin in adipose tissue of the obese induces insulin resistance. World J Diabetes. 2012 Jul 15;3 (7):135-41
  • Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest. 2004 Jul;114 (2):224-31
  • Steppan CM, Bailley ST, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA:. The Hormone Links Obesity to Diabetes. Nature. 409, 307-312, (2001) .
  • Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA:. A Family of Tissue-specific Resistin-like Molecules. PNAS. 98, 502-506, (2001) .
  • Steppan CM, Lazar MA. The current biology of resistin. J Intern Med. 2004 Apr;255 (4):
Related Products Docs